Transcendent Capital Group »

SPDR S&P Biotech shares owned by Transcendent Capital Group

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Transcendent Capital Group from 13F filings

Historical chart of Transcendent Capital Group investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Transcendent Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Transcendent Capital Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 20k 100.20
2024-09-30 $12k 120 98.80
2024-06-30 $1.6M 18k 92.71

More positions owned by Transcendent Capital Group

Allianzim Buffer 15 Uncapped Allocation Etf Allianzim Buf 15 (SPBU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Trust Etf Iv First Trust Enhanced Short First Tr Enh New (FTSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Ishares Tr S&p 500 Grwt Etf S&p 500 Grwt Etf (IVW)
Spdr Portfolio S&p 500 Etf Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Capital Group Core Equity Etf Shs Creation Unit Shs Creation Uni (CGUS)
Vanguard Large-cap Etf Large Cap Etf (VV)
Ishares Tr Core S&p Scp Etf Core S&p Scp Etf (IJR)
Ishares Tr Russell 2000 Etf Russell 2000 Etf (IWM)
Invesco S&p 500 Top 50 Etf S&p 500 Top 50 (XLG)

View all positions for Transcendent Capital Group

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech